RESPOND Study Grp 2022, ' Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting ', Open Forum Infectious Diseases, vol. 9, no. 3, 029 . https://doi.org/10.1093/ofid/ofac029 Greenberg, L, Ryom, L, Neesgaard, B, Miró, J M, Dahlerup Rasmussen, L, Zangerle, R, Grabmeier-Pfistershammer, K, Günthard, H F, Kusejko, K, Smith, C, Mussini, C, Menozzi, M, Wit, F, Van Der Valk, M, D'Arminio Monforte, A, De Wit, S D S, Necsoi, C, Pelchen-Matthews, A, Lundgren, J, Peters, L, Castagna, A, Muccini, C, Vehreschild, J J, Pradier, C, Bruguera Riera, A, Sönnerborg, A, Petoumenos, K, Garges, H, Rogatto, F, Dedes, N, Bansi-Matharu, L, Mocroft, A & RESPOND Study Group 2022, ' Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting ', Open Forum Infectious Diseases, vol. 9, no. 3, ofac029 . https://doi.org/10.1093/ofid/ofac029 Open forum infectious diseases, 9(3):ofac029. Oxford University Press